EUVIMEDEUVIMED entdecken
Open Access

Antibodies to varicella-zoster virus and three other herpesviruses and survival in adults with glioma

Geno Guerra iD, Lucie McCoy iD, Helen M Hansen, Terri Rice, Annette M Molinaro iD, Joseph L Wiemels, John K Wiencke, Margaret Wrensch, Stephen S Francis

Neuro-Oncology · 2023

DOI: 10.1093/neuonc/noac283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2023. Verfasst von Geno Guerra und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Glioma, Cytomegalovirus Infections. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCCDPHP CDC HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lifetime exposure to the varicella-zoster virus (VZV) has been consistently inversely associated with glioma risk, however, the relationship of VZV with survival in adults with glioma has not been investigated. In this study, we analyzed the survival of adults with glioma in relation to their antibody measurements to 4 common herpes viral infections, including VZV, measured post-diagnosis.

Methods

We analyzed IgG antibody measurements to VZV, cytomegalovirus (CMV), herpes simplex virus 1/2 (HSV), and Epstein-Barr virus (EBV) collected from 1378 adults with glioma diagnosed between 1991 and 2010. Blood was obtained a median of 3 months after surgery. Associations of patient IgG levels with overall survival were estimated using Cox models adjusted for age, sex, self-reported race, surgery type, dexamethasone usage at blood draw, and tumor grade. Models were stratified by recruitment series and meta-analyzed to account for time-dependent treatment effects.

Results

VZV antibody seropositivity was associated with improved survival outcomes in adults with glioma (Hazard ratio, HR = 0.70, 95% Confidence Interval 0.54–0.90, P = .006). Amongst cases who were seropositive for VZV antibodies, survival was significantly improved for those above the 25th percentile of continuous reactivity measurements versus those below (HR = 0.76, 0.66–0.88, P = .0003). Antibody seropositivity to EBV was separately associated with improved survival (HR = 0.71, 0.53–0.96, P = .028). Antibody positivity to 2 other common viruses (CMV, HSV) was not associated with altered survival.

Conclusions

Low levels of VZV or EBV antibodies are associated with poorer survival outcomes for adults with glioma. Differential immune response rather than viral exposure may explain these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsGliomaCytomegalovirus InfectionsAdultHumansHerpesvirus 3, HumanHerpesvirus 4, HumanSimplexvirusCytomegalovirusAntibodies, Viral

Stichwörter der Autor:innen

Epstein-Barr virusadult gliomaantibodies to varicella-zoster viruscytomegalovirusglioblastomaherpes simplex virussurvival

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
  • Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
  • Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
  • Center for Genetic Epidemiology, Department of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA.
  • Institute of Human Genetics, University of California San Francisco, San Francisco, California, USA.

ORCID-Profile: Geno Guerra, Lucie McCoy, Annette M Molinaro

Förderung

  • NCI NIH HHS
  • NCCDPHP CDC HHS
  • NCRR NIH HHS
  • National Institutes of Health
  • National Brain Tumor Foundation
  • National Center for Advancing Translational Sciences

Zitieren

APA

Guerra, G., McCoy, L., Hansen, H. M., Rice, T., Molinaro, A. M., Wiemels, J. L., Wiencke, J. K., Wrensch, M., & Francis, S. S. (2023). Antibodies to varicella-zoster virus and three other herpesviruses and survival in adults with glioma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noac283

Vancouver

Guerra G, McCoy L, Hansen HM, Rice T, Molinaro AM, Wiemels JL, et al. Antibodies to varicella-zoster virus and three other herpesviruses and survival in adults with glioma. Neuro-Oncology. 2023. doi:10.1093/neuonc/noac283

BibTeX
@article{Guerra2023,
  author = {Guerra, Geno and McCoy, Lucie and Hansen, Helen M and Rice, Terri and Molinaro, Annette M and Wiemels, Joseph L and Wiencke, John K and Wrensch, Margaret and Francis, Stephen S},
  title = {Antibodies to varicella-zoster virus and three other herpesviruses and survival in adults with glioma},
  journal = {Neuro-Oncology},
  year = {2023},
  doi = {10.1093/neuonc/noac283}
}
Kostenlos starten →